A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 81-88

  Foran, James M ^a   Gupta, Rajnish K ^a   Cunningham, David ^b   Popescu, Razvan A ^b   Goldstonk, Anthony H ^c   Sweetenham, John W ^d   Pettengell, Ruth ^e   Johnson, Peter W M ^f   Bessell, Eric ^g   Hancock, Barry ^h   Summers, Karin ^a   Hughes, Julia ⁱ   Rohatiner, Ama Z S ^a   Lister, T Andrew ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^h WESTON PARK HOSPITAL   (United Kingdom)

ⁱ ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

Anti CD20; Follicular lymphoma; Molecular remission; Rituximab; T(14; 18)

Indexed keywords

PROTEIN BCL 2; RITUXIMAB;

ADULT; AGED; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; BONE MARROW; CANCER REGRESSION; CLINICAL TRIAL; DRUG TOLERABILITY; FEMALE; FEVER; FOLLICULAR LYMPHOMA; HEADACHE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTICENTER STUDY; MYALGIA; NAUSEA; PAIN; PARESTHESIA; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIGOR; SKIN TOXICITY; TREATMENT OUTCOME; VERTIGO; VOMITING;

ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT; GENES, BCL-2; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MICE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 0034087362     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01965.x     Document Type: Article

References (46)

1. Apostolidis. J., Gupta, R.K., Grenzelias, D., Johnson, P.W.M., Pappa, V.l., Summers, K.E., Salam, A., Adams, K., Norton, A.J., Amess, J.A.L., Matthews, J., Bradburn, M., Lister, T.A. & Rohatiner, A.Z.S. (2000) High-dose therapy with autologous hone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. Journal of Clinical Oncology 18, 527-536.
2. Armitage, J.O. & Weisenburger, D.D. (1998) New approach to classifying non-Hodgkin's lyniphomas: clinical features of the major histologic subtypes. Journal of Clinical Oncology, 16, 2780-2795.
3. Bastion, Y., Berger, F., Bryon, P.-A., Felman, P., Ffrench, M. & Coiffier, B. (1991) Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Annals of Oncology, 2, 123-129.
4. Bastion, Y., Brice, P., Haioun, C., Sonet, A., Salles. G., Marolleau. J.P., Espinouse, D., Reyes, E., Gisselbrecht, C. & Coiffier, B. (1995) Intensive therapy with peripheral-blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86, 3257-3262.
5. Bierman, P.J., Vose, J.M., Anderson, J.R., Bishop, M.R., Kessinger, A. & Armitage, J.O. (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology. 15, 445-450.
6. Brittinger, G., Bartels, H., Common, H., Duhmke, E., Fulle, H.H., Gunzer, U., Gyenes, T., Heinz, R., Konig, E., Meusers, P., Paukstat, M., Pralle, H., Theml, H., Kopeke, W., Thieme, C., Zwingers, T., Musshof, K., Stacher, A., Brucher, H., Herrmann, F., Ludwig, W.D., Pribilla, W., Burger-Schuler, A., Lohr, G.W., Gremmel, H., Oerlei, J., Gerhartz, H., Koeppen, K.-M., Boll, I., Huhn, D., Binder, T., Schoengen, A., Nowicki, L., Pees, H.W., Schuerlen, P.G., Leopold, H., Wannenmacher, M., Schmidt, M., Loffler, H., Michlmayr, G., Thiel, E., Zettel, R., Ruhl, U., Wile, H.J., Schwarze, E.-W., Stein, H., Feller, A.C. & Lennert, K. (1984) Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas: results of a prospective multicentre study by the Kiel lymphoma study group. Haematological Oncology, 2, 269-306.
7. Cleary, M.L., Smith, S.D. & Sklar, J. (1986) Cloning and structural analysis of c-DNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t (14:18) translocation. Cell, 47, 19-28.
8. Coiffier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., Johnson, P., Lister, A., Feuring-Buske, M., Radford, J.A., Capdeville, R., Diehl, V. & Reyes, F. (1998) Rituximah (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma. A multicentre phase II study. Blood 92, 1927-1932.
9. Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., LoBuglio, A.F., Jonas, C., Klippenstein, D., Dallaire, B. & Varns, C. (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimaeric anti-CD20 monoclonal antibody and CHOP chemotherapy. Journal of Clinical Oncology, 17, 268-276.
10. Dana, B.W., Dahlberg, S., Nathwani, B.M., Chase, E., Coltman, C., Miller, T.P. & Fisher, R.I. (1993) Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. Journal of Clinical Oncology. 11, 644-651.
11. Darrington, D.L., Vose, I.M., Anderson, J.R., Bierman, P.J., Bishop, M.R., Chan, W.C., Morris, M.E., Reed, E.C., Sanger, W.G., Tarantolo, S.R., Weisenburger, D.D., Kessinger, A. & Armitage, J.O. (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem cell transplantation for lymphoid malignancies. Journal of Clinical Oncology. 12, 2527-2534.
12. Davis, T.A., White, C.A., Grillo-Lopez, A.J., Velasquez. W.S., Link, B., Maloney, D.G., Dillman, R.O., Williams, M.E., Mohrbacher, A., Weaver, R., Dowden, S. & Levy, R. (1999) Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. Journal of Clinical Oncology. 17, 1851-1857.
13. Freedman, A.S., Gribben, J.G., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Pandite, L., Robertson, M.J., Kroon, M., Ritz, J. & Nadler, L.M. (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780-2786.
14. Gall, E.A. & Mallory, T.B. (1942) Malignant lymphoma: a clinicopathologic survey of 618 cases. American Journal of Pathology 18, 381-429.
15. Gallagher, C.J., Gregory, W.M., Jones, A.E., Stansfeld, A.G., Richards, M.A., Dhaliwal, U.S., Malpas, J.S. & Lister, T.A. (1986) Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology. 4, 1470-1480.
16. Gribben, J.G., Freedman, A.S., Neuberg, D., Roy, D.C., Blake, K.W., Woo, S.D., Grossbard, M.L., Rabinowe, S.N., Coral, F., Freeman, G.J. & Nadler, L.M. (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New England Journal of Medicine, 325, 1525-1533.
17. Haas, R., Moos, M., Karcher, A., Mohle, R., Will, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685-1692.
18. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1592.
19. Horning, S.J. & Rosenberg, S.A. (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. New England Journal of Medicine, 311, 1471-1475.
20. Johnson, P.W.M., Rohatiner, A.Z.S., Whelan, J.S., Price, C.G.A., Love, S., Lim, J., Matthews, J., Norton, A.J., Amess, J.A.T., & Lister, T.A. (1995) Patterns of survival in patients with recurrent follicular lymphoma: a 20 year study from a single centre. Journal of Clinical Oncology, 13, 140-147.
21. Kaplan, E.S. & Meier, P. (1958) Non-parametric estimation from incomplete observation. American Statistics Association Journal 53, 457-480.
22. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene, 6, 2271-2276.
23. Link, B.K., Grossbard, M.L., Fisher, R.I., Czuczman, M.S., Gilman, P., Lowe, A.M. & Vase, J.M. (1998) Phase II pilot study of the safety and efficacy of rituximab in combination with CHOP chemotherapy in patients with previously-untreated intermediate-or high-grade non-Hodgkin's lymphoma (Abstract). Proceedings of the American Society of Clinical Oncology, 17, 7a.
24. Lister, T.A., Cullen, M.H., Beard, M.E.J., Brearley, R.L., Whitehouse, J.M.A., Wrigley, P.F.M., Stansfeld, A.G., Suteliffe, S.B.J., Malpas. J.S. & Crowther, D. (1978) Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. British Medical Journal, 1, 533-537.
25. Liu, Y., Hernandez, A.M., Shibata, D. & Cortopassi, G.A. (1994) Bcl-2 translocation frequency rises with age in humans. Proceedings of the National Academy of Sciences of the United States of America, 91, 8910-8914.
26. Lopez-Guillermo, A., Cabanillas, F., McLaughlin, P., Smith, T., Hagemeister, F., Rodriguez, M.A., Romaguera, J.E., Younes, A., Sarris, A.H., Preti, A., Pugh, W. & Lee, M.-S. (1998) The clinical significance of molecular response in indolent follicular lymphoma. Blood, 91, 2955-2960.
27. MacManus, M.P. & Hoppe, R.T. (1996) Is radiotherapy curative for stages I and II low-grade follicular lymphoma? Results of a longterm follow-up study of patients treated at Stanford University. Journal of Clinical Oncology, 14, 1282-1290.
28. Maloney, D.G., Lues, T.M., Czerwinski, D.K., Waldichul, C., Rosenberg, J., Grillo-Lopez, A. & Levy, R. (1994) Phase I clinical trial using escalating single-dose infusion of chimaeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood, 84, 2457-2466.
29. Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.-M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. & Levy, R. (1997a) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90, 2188-2195.
30. Maloney, D.G., Grillo-Lopez, A.J., Bodkin, D.J., While, C.A., Liles, T.-M., Royston, I., Varns, C., Rosenberg, J. & Levy, R. (1997b) IDEC-C2BS: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 15, 3266-3274.
31. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy. R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. & Dallaire, B.K. (1998) Rituximab chimaeric anti-CD2D monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825-2833.
32. Miller, J.S., Arthur, D.C., Litz, C.E., Neglia, J.P., Miller, W.J. & Weisdorf, D.J. (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood, 83, 3780-3786.
33. Nguyen, D., Amess, J., Doughty, H., Foran, J. & Lister, T.A. (1997) IDEC-C2B8 anti-CD20 immuno-therapy in patients with non-Hodgkin's lymphoma: hematological effects in the bone marrow and peripheral blood (Abstract). Blood, 90 (Suppl. 1). 511a.
34. Nguyen, D.T., Ames, J.A., Doughty, H., Hendry, L. & Diamond, L.W. (1999) IDEC-C2B8 anti-CD20 (Rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response in 48 patients. European Journal of Haematology, 62. 76-82.
35. Portlock, C.S., Rosenberg, S.A., Glatstein, E. & Kaplan, H.S. (1976) Treatment of advanced non-Hodgkin's lymphomas with favorable histology: preliminary results of a prospective trial. Blood, 47, 747-756.
36. Price, C.G.A., Meerabux, J., Murtagh, S., Cotter, F.E., Rohatiner, A.Z.S., Young, B.D. & Lister, T.A. (1991) The significance of circulating cells carrying t (14:18) in long remission from follicular lymphoma. Journal of Clinical Oncology, 9, 1527-1532.
37. Rauzy, O., Galoin, S., Chale, J.-J., Adoue, D., Albarede, J.-L, Delsol, G. & Al Saati, T. (1998) Detection of t (14:18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Journal of Clinical Pathology: Molecular Pathology, 51, 333-338.
38. Reff, M.E., Carner, K., Chambers, K.S., Chinn, P.C., Leonard, J.E., Raab, R., Newman, R.A., Hanna, N. & Anderson, D.R. (1994) Depletion of B-cells in vivo by a chimaeric mouse human monoclonal antibody to CD20. Blood, 83, 435-445.
39. Rogers, J., Jackson, J., Rosenberg, J., Varns, C., Leonard, J. & Grillo-Lopez, A.J. (1996) Clearance of bcl-2 (t 14:18) from peripheral blood and bone marrow in patients with relapsed low-grade or follicular (IWF: A-D) lymphoma following single-agent therapy with the chimaeric anti-CD20 antibody IDEC-C2B8. (Proceedings VI International Conference on Malignant Lymphoma; Abstract). Annals of Oncology, 7, 108a.
40. Rohatiner, A.Z.S., Johnson, P.W.M., Price, C.G.A., Arnott, S.J., Amess, J.A.L., Norton, A.J., Dorey, E., Adams, K., Whelan, J.S., Matthews, J., MacCallum, P.K., Oza, A.M. & Lister, T.A. (1994) High dose therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology, 12, 1177-1184.
41. Shan, D., Ledbetter, J.A. & Press, O.W. (1998) Apoptosis of malignant B cells by ligation of CD20 with monoclonal antibodies. Blood, 91, 1644-1652.
42. Stone, R.M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M., Rabinowe, S.N., Aster, J.C., Leavitt, P., Mauch, P., Freedman, A.S. & Nadler, L.M. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 2535-2542.
43. Tedder, T.F. & Engel, P. (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunology Today, 15, 450-454.
44. Weiss, L.M., Warnke, R.A., Sklar, J. & Cleary, M.L. (1987) Molecular analysis of the t (14;18) chromosomal translocation in malignant lymphomas. New England Journal of Medicine, 317, 1185-1189.
45. Yunis, J.J., Oken, M.M., Kaplan, M.E., Ensrud, K.M., Howe, R.R. & Theologides, A. (1982) Distinctive chromosomal abnormalities in histologie subtypes of non-Hodgkin's lymphoma. New England Journal of Medicine, 307, 1231-1236.
46. Zhou, L.J. & Tedder, T.F. (1995) CD20 workshop panel report. In: Leucocyte Typing, V White Cell Differentiation Antigens. Proceedings of the Fifth International workshop and conference, Boston, USA, 3-7 November 1993 (ed. by S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Marian, T. Kishimoto, C. Morimotot, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder & R.F. Todd). pp. 511-514. Oxford University Press, Oxford.